|This message contains images. If you don't see images, click here to view.|
Advertise in this news brief.
Not an AzPA member?
Not an AzPA member? Join the only statewide association representing all pharmacy professionals in all pharmacy practice settings.
Webinar available: DEA Final Rule for disposal of controlled substances
The Arizona Pharmacy Association has partnered with the Pharmacy Society of Wisconsin to make available an online, continuing education course on the DEA Final Rule for the Disposal of Controlled Substances. The release of the DEA Final Rule regarding disposal of controlled substances provides for expanded methods of controlled substance disposal for community members, patients and long-term care facility residents. The rule has significant implications for pharmacies, hospitals/clinics, long-term care facilities, hospice, law enforcement and others. This webinar provides an overview of the DEA Final Rule.
The registration fee for this course is $95. CE for this webinar is available for pharmacists and pharmacy technicians.
Those that register for this webinar have access to the following resources.
To register for this course, click here. You will need to select the "log-in" option to create a user account in order to process your registration. Questions can be directed to firstname.lastname@example.org.
- Recorded webinar
- Written analysis of the Final Rule
- Webinar slides
- Links to additional resources from DEA
Register now for ACPE-approved self-paced online seminars
The Arizona Pharmacy Association invites you to register for the following ACPE-approved self-paced online seminars:
Or purchase the entire bundle for a total of 12.5 Contact Hours and save 20 percent! Visit education.azpharmacy.org to search the entire online education catalog and register for additional live webiners or self-study programs!
University of Arizona College of Public Health requests your participation in a survey
University of Arizona
The University of Arizona College of Public Health is conducting this survey with the support of Arizona State Board of Pharmacy, Arizona Pharmacy Association, University of Arizona College of Pharmacy and Midwestern College of Pharmacy. This confidential survey will take about 15 minutes to complete. Your participation is crucial to get an accurate understanding of pharmacist practice in Arizona. Your responses will be reported in the aggregate to assure confidentiality. The results from this study will provide actionable information to improve the training, recruitment and retention.
Dec. 10 is the last day to share your perspective of where pharmacy will be at five years from now.
All participants who complete the survey by Dec. 10 will be automatically entered into a drawing to win a professional ASHP reference book of their choice (maximum of $125). Special thanks to the 972 that have responded to the survey thus far.
Arizona Opioid Prescribing Guidelines
The final version of the Arizona Opioid Prescribing Guidelines — a voluntary, consensus set of guidelines that promote best practices for prescribing opioids for acute and chronic pain. The goal of these guidelines is to balance the appropriate treatment of pain with approaches to more safely prescribe opioids. The guidelines are intended for use by a variety of clinicians in primary care and specialty outpatient settings who treat acute pain and/or manage chronic pain that is not occurring at the end of life and not due to malignancy. These Arizona Opioid Prescribing Guidelines complement other statewide documents articulating best practices for Emergency Department Controlled Substance Prescribing and Dispensing Controlled Substances.
Save $35 register today: Southwestern Clinical Pharmacy Seminar
Join AzPA at JW Marriott in Tucson this Feb. 21-22 for our Southwestern Clinical. This is your chance to earn up to 12 CPEs. Attend sessions on drug updates, medication adherence, pharmacy law and more. Full schedule coming soon. Save $35 with early bird pricing ending Jan. 16.
Save $50 if you register before Jan. 16: Anticoagulation Certificate Program
Join AzPA at JW Marriott in Tucson Feb. 20 for a comprehensive Anticoagulation Certificate program designed to provide pharmacists with the basic knowledge to care for patients taking anticoagulation therapies. By completing this course, pharmacists can earn 22 hours of continuing education credit while becoming certified in anticoagulation management. Register today!
Miss an issue of the AzPA Pharmacy Flash? Click here to visit the AzPA Pharmacy Flash archive page.
||ASHP Midyear Clinical Meeting and Exhibition
||Anticoagulation Certificate Program 2015
||Southwestern Clinical Pharmacy Seminar
Should health insurance pay for compounded medications?
By Jason Poquette
Former President Ronald Reagan once quipped that the nine most terrifying words in the English language are: "I'm from the government, and I'm here to help." Today, it seems like we could exchange the words "the government" with "your insurance" with exactly the same sentiment, and we wouldn't be far off. The latest development in the insurance industry is the controversy initiated by Express Scripts through their denial of claims from compounding pharmacies for customized compounded medication.
Pharmacists play critical role in HIV care
Pharmacy Practice News
Nearly three-fourths of patients hospitalized with HIV infection are at risk for antiretroviral therapy drug errors that could seriously compromise their care, a new study suggests. Moreover, the errors are far more likely to be caught and resolved when pharmacists with specialized training review the complex treatment regimens, according to the investigators.
CMS-funded project to create community pharmacist network
Cutting costs is a key aim of health care reform. Joe Moose, PharmD, believes community pharmacists have a major role to play in reaching this goal. While prescription drugs account for only about 10 to 15 percent of health care spending, Moose says pharmacy's ability to affect cost isn't limited to drugs alone. Given the authority and reimbursed fairly, pharmacists could significantly reduce the other 85 to 90 percent of health care spending, Moose says.
Missed last week's issue? See which articles your colleagues read most.
Survey: Cost trumps health for many Americans
By Scott E. Rupp
As Obamacare is entering its second year of implementation, a new survey showcases consumer's thoughts about the Affordable Care Act and health insurance. Conducted ahead of the 2015 open enrollment, the survey shows health insurance issues, including factors impacting health plan selection, satisfaction with current plan options, consumer understanding of the ACA, perceived impact of the ACA and overall thoughts about the U.S. health insurance system.
From plant to pharmacy — Texas Tech researchers create new medicinal use for cotton
If it looks to you like plastic film, its base product might surprise you. Meet Texas Tech's future biodegradable bandage. When the cotton-based product is available for widespread use — which its creators admit might not be for some time — it can be applied with medicinal ointment to a wound site. Unlike traditional bandages, it need not be removed later.
Pharmacy students offer health screenings to the homeless
A group of Ohio medical students are putting their skills to good use for those less fortunate. Pharmacy, psychology, physician assistant and medical students from Wright State University, Cedarville University, Kettering College and the University of Dayton are offering health screenings to the homeless as part of the Students Teaching Educational Plans for Success program, according to Dayton Daily News.
Amoxicillin use linked to diarrhea and thrush
Medical News Today
Researchers have found that taking the common antibiotics amoxicillin and amoxicillin-clavulanic acid can result in symptoms of diarrhea and candidiasis, also known as thrush. Not only that, but these adverse effects could also be underreported, leading to a high prevalence of prescriptions.
FDA advisory panel says steroid shots for back pain can continue
An expert advisory panel to the U.S. Food and Drug Administration decided not to recommend the agency issue a strong warning against the general use of steroid injections for back pain. The shots are commonly used to treat back pain, but they have never been approved for this use by the FDA, and whether their risks outweigh their benefits has long been a matter of debate.
Common indigestion medicine could be used in fight against cancer
Medical News Today
The drug cimetidine can increase survival rates in colorectal cancer cases, according to the study published in ecancer. "Cimetidine is an interesting drug as it's very safe, very well-known, and has clinical results in cancer that have been confirmed in a number of trials," says lead author Dr. Pan Pantziarka, a member of the Repurposing Drugs in Oncology project.
| Looking for similar articles? Search here, keyword CANCER.|
AzPA Pharmacy Flash
Colby Horton, Vice President of Publishing, 469.420.2601
Download media kit
Danielle Wegert, Assistant Executive Editor, 469.420.2696
Disclaimer: The AzPA Pharmacy Flash is a weekly roundup of articles of interest to pharmacists and pharmacy professionals. This email may contain an advertisement of AzPA and/or third party products and services. Opinions expressed in these articles do not necessarily reflect the views of AzPA or its advertising partners. The AzPA Pharmacy Flash is compiled by MultiBriefs, a division of MultiView, Inc. Factual errors are the responsibility of the listed publication.
This edition of the AzPA Pharmacy Flash was sent to ##Email##. To unsubscribe, click here. Did someone forward this edition to you? Subscribe here — it's free!
Nov. 26, 2014
Nov. 19, 2014
Nov. 12, 2014
Nov. 5, 2014
7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063